paclitaxel has been researched along with Carbon Tetrachloride Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, J; Feng, GG; Huang, L; Ishikawa, N; Ito, Y; Koide, T; Kurokawa, T; Li, C; Nonami, T; Sugiyama, S; Tsunekawa, K | 1 |
| Fujita, H; Kojima, H; Mase, H; Okamoto, M; Takao, A | 1 |
2 other study(ies) available for paclitaxel and Carbon Tetrachloride Poisoning
| Article | Year |
|---|---|
Roles of naofen, a novel WD-repeat-2 protein, in the CCl4-treated livers--a possible relationship to cell proliferation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbon Tetrachloride Poisoning; Cell Count; Cell Line; Cell Proliferation; Cells, Cultured; Hepatectomy; Hepatocytes; Humans; Immunohistochemistry; In Situ Hybridization; Kinetics; Liver; Liver Cirrhosis, Experimental; Male; Mitosis; Paclitaxel; Proteins; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A | 2008 |
[Pharmacokinetics of paclitaxel in experimental animals. Part 2. Tissue distribution].
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Female; Half-Life; Injections, Intravenous; Liver Diseases; Male; Mice; Mice, Inbred ICR; Paclitaxel; Rabbits; Sarcoma 180; Tissue Distribution | 1994 |